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Abstract
Acetylcholinesterase (AChE) and butyrylcholinesterase (BChE) are irreversibly inhibited by 
organophosphorus pesticides through formation of a covalent bond with the active site serine. 
Proteins that have no active site serine, for example albumin, are covalently modified on tyrosine 
and lysine. Chronic illness from pesticide exposure is not explained by inhibition of AChE and 
BChE. Our goal was to produce a monoclonal antibody that recognizes proteins 
diethoxyphosphorylated on tyrosine. Diethoxyphosphate-tyrosine adducts for 13 peptides were 
synthesized. The diethoxyphosphorylated (OP) peptides crosslinked to 4 different carrier proteins 
were used to immunize, boost, and screen mice. Monoclonal antibodies were produced with 
hybridoma technology. Monoclonal antibody depY was purified and characterized by ELISA, 
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Western blotting, Biacore and Octet technology to determine binding affinity and binding 
specificity. DepY recognized diethoxyphospho-tyrosine independent of the amino acid sequence 
around the modified tyrosine and independent of the identity of the carrier protein or peptide. It 
had an IC50 of 3 × 10−9 M in a competition assay with OP tubulin. Kd values measured by Biacore 
and OctetRED96 were 10−8 M for OP-peptides and 1 × 10−12 M for OP-proteins. The limit of 
detection measured on Western blots hybridized with 0.14 μg/mL depY was 0.025 μg human 
albumin conjugated to YGGFL-OP. DepY was specific for diethoxyphospho-tyrosine (chlorpyrifos 
oxon adduct) as it failed to recognize diethoxyphospho-lysine, phosphoserine, phospho-tyrosine, 
phospho-threonine, dimethoxyphospho-tyrosine (dichlorvos adduct), dimethoxyphospho-serine, 
monomethoxyphospho-tyrosine (aged dichlorvos adduct), and cresylphospho-serine. In 
conclusion, a monoclonal antibody that specifically recognizes diethoxyphospho-tyrosine adducts 
has been developed. The depY monoclonal antibody could be useful for identifying new 
biomarkers of OP exposure.
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Introduction
Organophosphorus pesticides can have the same toxic effects as chemical warfare agents 
because they share the same mechanism of acute toxicity, namely irreversible inhibition of 
acetylcholinesterase (AChE).1 Furthermore, organophosphorus pesticides are readily 
available to persons intent on harming others. Taliban insurgents have poisoned schoolgirls 
in Afghanistan with parathion in several attacks. Proof of exposure can be obtained from 
blood samples drawn more than a month after the event through mass spectrometry analysis 
of diethoxyphospho-tyrosine adducts on blood proteins. A study by van der Schans found 
that the adduct on tyrosine 411 of human albumin was detectable in blood drawn 49 days 
after poisoning by chlorpyrifos.2 The same blood sample contained no detectable adducts on 
butyrylcholinesterase (BChE) because new BChE molecules had replaced the inhibited 
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BChE. It is expected that a monoclonal antibody specific for diethoxyphospho-tyrosine 
could be used to detect exposure in a device similar to the one developed by Rapid Pathogen 
Screening, Inc.3 for nerve agent exposure. Such a device is simple to use and requires no 
expensive mass spectrometers.
A second application of a monoclonal antibody to diethoxyphosphorylated (OP) tyrosine 
would be for understanding chronic neurotoxicity from organophosphorus pesticide 
exposure. To date the only proteins known to be modified by organophosphorus pesticides in 
vivo are acetylcholinesterase, butyrylcholinesterase, carboxylesterase, and albumin. Acyl 
peptide hydrolase in red blood cells is a possible target, but evidence for reaction with 
organophosphorus pesticides in vivo has been demonstrated only in rats and only with 
dichlorvos.4 The proposed monoclonal antibody could be used to immunopurify 
diethoxyphospo-tyrosine-containing proteins in preparation for analysis by mass 
spectrometry. This would test the hypothesis that organophosphorus toxicants modify many 
proteins and that the consequence of modification is disruption of signaling pathways.5
The strategy we used to make our monoclonal antibody to diethoxyphospho-tyrosine is 
based on the strategy that produced the monoclonal antibody to phospho-tyrosine. 6 We 
conjugated 4 carrier proteins to 13 different OP-tyrosine peptides. Five conjugates were used 
as immunogen, a different 5 for boosting, and a different three for screening.
Materials and Methods
The following were from Sigma-Aldrich: human albumin, (accession P02768) Fluka 05418; 
bovine albumin (P02769) A-2153 and A-8022; ovalbumin (P01012) A-5503; lysozyme 
(P00698) L-6876; casein (mixture of isoforms P02662, PO2663, P02666, P02668) C-5890; 
aprotinin bovine (P00974) A-1153; Anti O-Phospho-tyrosine monoclonal antibody clone 
PY20 (Sigma P-4110); O-Phospho-L-tyrosine P-9405; 2-[Nmorpholino] ethanesulfonic acid 
M-8250; O-Phenylenediamine dihydrochloride P-8287; 1- ethyl-3-(3-dimethylaminopropyl) 
carbodiimide.HCl, Fluka 03450; Paraoxon-ethyl D-9286.
The following were from Thermo Scientific: Sulfo-NHS, N-hydroxysulfosuccinimide 
24510; 3,3′,5,5′-tetramethylbenzidine solution N301; Nunc-Immuno MaxiSorp surface flat 
bottom 96 well polystyrene plate; Immulon 2HB Thermo 3455. The following were from 
Chem Service Inc: Chlorpyrifos oxon MET-674B; Dichlorvos PS-89. Peptides were 
purchased from American Peptide Co., Sigma-Aldrich, and Genscript. Mouse albumin 
(P07724) was from Innovative Research Inc., Novi, MI. Porcine tubulin (mixture of alpha 
and beta P02550, Q2XVP4, Q767L7, P02554) was from Cytoskeleton Inc T240. Protein G 
agarose was from Protein Mods LLC, Madison, WI. Horse anti-mouse IgG (heavy and light 
chains) conjugated to HRP was from Cell Signaling 7076. CNBr-activated Sepharose fast 
flow was from Amersham Biosciences 17-0981-01.
OP-Tyrosine peptides
Diethoxyphospho-tyrosine adducts formed spontaneously when peptides were incubated 
with an excess of chlorpyrifos oxon (CPO) or paraoxon at high pH. For example 70 mg of 
peptide YGGFL were incubated in 12 mL of 1 M Tris pH 10.8 with a 33 fold molar excess 
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of paraoxon (0.1 mL of 4.16 M paraoxon) for 3 days at 37°C. During this time the pH 
dropped to pH 9. Unreacted paraoxon was separated from p-nitrophenol and peptides by 
extraction with chloroform. The yellow p-nitrophenol was separated from peptides on a C18 
Alltech 900 mg cartridge or on a SepPak C18 cartridge (Waters) where the p-nitrophenol 
eluted with 0.1% (v/v) TFA in water, and the peptides eluted with 3 to 50% (v/v) 
acetonitrile. OP-labeled peptide was separated from unlabeled peptide by HPLC on a C18 
Phenomenex column using a 1 h gradient from 0.1% TFA in water to 60% (v/v) acetonitrile. 
At each step, fractions containing the OP-peptide and the unlabeled peptide were identified 
by MALDI-TOF mass spectrometry (4800 MALDI-TOF-TOF mass spectrometer, AB 
Sciex). Fragmentation analysis of the OP-peptide identified tyrosine as the residue modified 
by OP.
In a second example, 80 mg of peptide RSLYAS in 5.5 mL of 0.1 M sodium carbonate pH 
10 was incubated with a 30-fold molar excess of CPO at 24°C for 24 h. Comparison of peak 
intensities in the MALDI-TOF mass spectrometer showed that 60% of the peptide had been 
diethoxyphosphorylated on tyrosine. Excess CPO was extracted into chloroform. The OP-
peptide was isolated by HPLC as above.
Quantitation of OP-peptide
The relationship between peptide quantity and absorbance in the UV range was established 
as follows. Peptide concentration was determined by the Protein Structure core facility at the 
University of Nebraska Medical Center. Triplicate volumes of 3 funlabeled and 3 OP-
peptide solutions were hydrolyzed and the amino acids quantified by reaction with 
ninhydrin. The absorbance spectra of the same peptide solutions were acquired on a Gilford 
spectrophotometer. Unlabeled peptides containing one tyrosine but no other aromatic 
residues, had an absorbance peak at 275 nm and an absorbance of 1500 for a 1 M solution in 
water measured in a 1 cm quartz cuvette (E275nm = 1500 M−1 cm−1). The same peptides 
modified on tyrosine by OP had an absorbance peak at 265 nm and an absorbance of 430 for 
a 1 M solution in water in a 1 cm quartz cuvette (E265nm = 430 M−1 cm−1).
Coupling of OP-tyrosine peptides to carrier proteins
OP-peptides were conjugated to carrier proteins using a procedure adapted from Belabassi et 
al. 7 For example, 1.9 mg of bovine serum albumin (BSA) in 720 μl of 0.1 M 2-[N-
morpholino]ethanesulfonic acid (MES) pH 6.2 was conjugated to 4 mg of OP-peptide in the 
presence of 2.1 mg N-hydroxysulfosuccinimide (Sulfo-NHS) and 4.7 mg of 1-ethyl-3-(3 
dimethylaminopropyl) carbodiimide (EDC). The pH was adjusted to pH 6.2 with 5 M NaOH 
measured with pH strips. The 0.8 mL reaction volume was mixed in a rotating mixer (Roto-
Torque rotating mixer, Cole Parmer Instruments) for 3 h at room temperature. Excess 
reagents were separated from OP-peptide-BSA by passage through a Dextran desalting 
column 5K molecular weight cut off.
MALDI-TOF mass spectrometry to quantify number of OP-peptides crosslinked to carrier 
proteins
The number of OP-peptides crosslinked to the carrier proteins BSA, human serum albumin 
(HSA), ovalbumin (OVA) and lysozyme was quantified from the shift in mass of the carrier 
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protein observed in the MALDI-TOF mass spectrometer, as described by Belabassi et al.7 
Proteins were spotted onto a MALDI target plate with sinapinic acid. Mass data were 
acquired in a 4800 MALDI-TOF/TOF mass spectrometer (AB Sciex) set to linear high mass 
positive mode, range 30,000 to 100,000 Da, bin size 20 ns, detector voltage multiplier 0.95, 
delayed extraction 1650 nsec, low mass gate enabled, low mass gate offset 100 Da, collected 
3000 shots with laser voltage set to 7800 V. The list of OP-tyrosine peptides conjugated to 
BSA, HSA, OVA and lysozyme is in Table S1 in the Supporting Information section. 
Samples are in 0.1 M MES buffer pH 6.2 at a concentration of 2.5 mg protein per mL.
Production of monoclonal antibodies
Antibodies were generated in mice by Syd Labs, Inc. using standard hybridoma fusion 
technology. Mice were immunized with BSA conjugated to 5 peptides 
diethoxyphosphorylated on tyrosine: PVYSR-OP, LYGLPR-OP, KYA-OP, HYRGPA-OP, 
and EPNVSY-OP. Mice were boosted with OVA conjugated to 3 peptides 
diethoxyphosphorylated on tyrosine: RSLYAS-OP, YGGFL-OP, YPF-OP and HSA 
conjugated to PPYRM-OP and QYDVRK-OP. Hybridomas were screened using lysozyme 
conjugated to RARYEM-OP, GGYR-OP, and KYK-OP. Thirty hybridoma culture media 
were rescreened with human albumin and mouse albumin modified by CPO. Hybridoma 
cells in well 3B9 were grown in 10% (v/v) fetal calf serum in Dulbecco’s Modified Eagle’s 
Medium containing proprietary components (ProMab M10009). Monoclonal antibody in 
580 mL culture medium was purified on a 10 mL column of Protein G agarose, yielding 19 
mg of monoclonal antibody in 0.055 M citrate, 0.44 M potassium phosphate pH 6.7. The 
purified monoclonal antibody was named depY where dep is an abbreviation for 
diethoxyphosphate and Y is the code name for tyrosine.
DepY immobilized on Sepharose beads
CNBr-activated Sepharose (1 g) washed and swollen to 3 mL, was coupled to 4.7 mg of 
monoclonal antibody depY in 1 mL of 0.15 M sodium bicarbonate, 0.5 M NaCl pH 8. The 
quantity of bound depY was calculated from absorbance at 280 nm of the unbound 
supernatant compared to absorbance at 280 nm before crosslinking. It was calculated that 
4.5 mg of depY was covalently bound to 3 mL Sepharose. The beads were washed with pH 
8 buffer, 1 M NaCl, pH 3.5 buffer, and phosphate buffered saline (PBS). Beads were stored 
in 15 mL of PBS, 0.1% (w/v) azide. A 0.1 mL suspension contained 20 μl beads covalently 
bound to 30 μg of depY.
Dichlorvos modified peptide and immuno MALDI
Dichlorvos makes the dimethoxyphospho adduct and ages to the monomethoxyphospho 
adduct on tyrosine. 8, 9 Chlorpyrifos oxon makes the diethoxyphospho adduct on tyrosine 
and does not age. 2, 10–13 To determine whether depY could distinguish between 
dimethoxyphospho-tyrosine (from dichlorvos) and diethoxyphospho-tyrosine (from 
chlorpyrifos) we synthesized the corresponding adducts on tyrosine in short peptides. 
Synthesis of the diethoxyphospho-tyrosine adduct on peptide YGGFL is described above. 
Synthesis of the dimethoxyphospho-tyrosine adduct on peptide GGYR was performed as 
follows. Peptide GGYR (Sigma G5386), 2.7 mM in 1 M Tris pH 10, was incubated with 81 
mM dichlorvos at 37°C. After 12 days about 50% of the peptide was modified on tyrosine. 
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The dichlorvos modified peptide was partially purified by HPLC on a C18 column. The 
identity of the modified residue, tyrosine, was determined by fragmentation analysis in the 
4800 MALDI-TOF/TOF mass spectrometer. Binding to immobilized depY was evaluated by 
incubating 20 μl beads in 0.3 mL PBS with 0.01 mL of dichlorvos-GGYR and 
diethoxyphospho-tyrosine peptide YGGFL-OP for 2 h at room temperature. The negative 
control sample to check for nonspecific binding to Sepharose beads (no antibody) contained 
beads incubated with dichlorvos-GGYR and YGGFL-OP. Beads were washed with PBS and 
water. Bound peptides were released with 50% acetonitrile,1% TFA and visualized by 
MALDI-TOF mass spectrometry with α-Cyano-4-hydroxycinnamic acid matrix. 
Monoisotopic masses for the positively charged ions are 560.2 (dimethoxyphospho-tyrosine 
adduct on GGYR), 546.2 (monomethoxyphospho-tyrosine adduct on GGYR) and 692.2 for 
YGGFL-OP (diethoxyphospho-tyrosine adduct on YGGFL).
Proteins treated with chlorpyrifos oxon
OP-proteins for ELISA and Western blots were produced by incubating 0.5 mg/mL bovine 
tubulin, porcine tubulin, human albumin, mouse albumin, casein, lysozyme, and aprotinin 
with 1.5 mM CPO in 20 mM TrisCl pH 8.9, 0.01% azide at room temperature for 7 days. 
Tryptic peptides of CPO-treated proteins were analyzed by LC-MS/MS to identify and 
quantify the modified residues. Appendix S1 in the Supporting Information section lists the 
modified residues and the extent of modification.
O-phospho-tyrosine conjugated to human albumin
Phosphorylated tyrosine is naturally present on many proteins in all cells.14 To determine 
whether a commercially available monoclonal antibody to phosphorylated tyrosine 
recognizes diethoxyphosphorylated-tyrosine we performed the following experiment. We 
prepared a positive control by crosslinking O-phospho-L-tyrosine to human albumin. O-
phospho-L-tyrosine (2 mg in 0.5 mL 0.1 M MES, 0.9 M NaCl, 0.02% azide pH 4.7) was 
crosslinked to 0.2 mL of 10 mg/mL human albumin with EDC. After 2 h reaction at room 
temperature the sample was freed of excess reagents on a 5 mL desalting column.
A set of diethoxyphosphorylated proteins and the positive control were subjected to SDS gel 
electrophoresis followed by transfer to a PVDF membrane. The membrane was hybridized 
with 0.5 μg/mL of anti O-phospho-L-tyrosine monoclonal antibody clone PY20 (Sigma 
P-4110) and visualized with an HRP-conjugated secondary antibody.
Lysine-OP conjugated to human albumin
To determine whether depY recognized lysine-OP, we prepared diethoxyphospholysine by 
incubating 2 mM L-lysine in 25 mM ammonium bicarbonate pH 8 with 20 mM CPO at 
37°C for 9 days. MALDI-TOF mass spectrometry indicated that 50% of the 147 Da lysine 
had acquired an added mass of 136 to make an adduct of mass 283 Da. Excess CPO and 
unreacted lysine were separated from lysine-OP by passage through a C18 cartridge.
Human albumin (1.9 mg) in 800 μl of 0.1 M MES pH 6.2 was conjugated to 0.45 mg of 
lysine-OP in the presence of 2.1 mg Sulfo-NHS and 4.7 mg EDC. The pH was adjusted to 
pH 6.2 with 5 M NaOH measured with pH strips. The 0.8 mL reaction volume was mixed in 
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a rotating mixer for 3 h at room temperature. Excess reagents were removed by passage 
through a Dextran desalting column 5K molecular weight cut off. MALDI-TOF mass 
spectrometry in sinapinic acid indicated that each albumin molecule bound 14 lysine-OP.
The human albumin-lysine-OP conjugate was coated on an immulon plate at 1 μg per well. 
Control samples were human albumin (no OP) and the positive control, tubulin-OP. Binding 
of depY was evaluated by ELISA using a depY concentration of 0.2 μg in 100 μl.
ELISA
Immulon 96-well plates were coated with 1 μg antigen in 100 μL of pH 9.6 coating buffer (3 
g Na2CO3 and 6 g NaHCO3 in 1 L water) per well at 4°C overnight. Wells were blocked 
with 1% (w/v) BSA in Tris buffered saline 20 mM TrisCl, 0.15 M NaCl pH 7.4 (TBS) at 
room temperature for 1 h, followed by one wash with TBS containing 0.05% (v/v) Tween-20 
(TBST). Monoclonal antibody depY diluted to 0.02 μg/100 μL in 1% BSA/TBS was added 
to the wells. The plate was rocked 2 h at room temperature, washed 3 times with TBST, and 
incubated with horse radish peroxidase (HRP) conjugated anti-mouse IgG, 5 μL diluted into 
20 mL of 1% BSA/TBS for 2 h at room temperature. After the plate was washed 5 times 
with TBST, wells received 100 μL of 3,3′,5,5′-tetramethylbenzidine (TMB) or a freshly 
prepared solution of O-phenylenediamine dihydrochloride (4 mg tablet in 10 mL of 0.05 M 
phosphate-citrate pH 5.0 with 10 μl of 30% hydrogen peroxide). The HRP reaction was 
stopped after 20 min by addition of 100 μL of 0.16 M sulfuric acid. Absorbance at 405 nm 
for TMB reactions, or at 490 nm for O-phenylenediamine reactions, was recorded on a 
BioTek 96-well plate reader (Winooski, VT).
Western blot
Samples containing 1 μg protein (Figure 2) or 5 to 100 ng protein (Figure 4) were 
electrophoresed on 4–20% (w/v) gradient precast gels (BioRad 456-8093). After 
electrophoresis proteins were electroblotted onto PVDF membrane. The membrane was 
hybridized with depY diluted to 0.14 μg/mL in 5% (w/v) non-fat milk in TBS at 4°C 
overnight. The membrane was washed 3 times with TBST and hybridized with 1:10,000 
diluted secondary antibody (horse anti-mouse IgG conjugated to HRP) for 1 h at room 
temperature in 5% non-fat milk in TBS. Excess reagents were washed off with TBST. The 
signal was developed with Pierce ECL Western Blotting reagent (#32209) detected on X-ray 
film.
Kd evaluated by competition ELISA
The ability of tubulin-OP to bind depY was evaluated by competition ELISA. A 96-well 
plate was coated with 1 μg per well of human albumin-QYDVRK-OP. The depY antibody 
diluted to 0.1 μg/mL in 1% BSA, pH 7.4 buffer was incubated with porcine tubulin-OP 
concentrations ranging from 10−17 M to 10−7 M for 1 h at room temperature. The mixtures 
were added to the 96-well plate and the availability of depY to bind the OPprotein in the 
wells was quantified from the signal intensity of the bound HRP-conjugated secondary 
antibody.
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Kd of OP-peptides evaluated by Biacore analysis
Binding experiments were performed on a Biacore T-200 instrument at 25°C. The depY 
antibody was immobilized on a CM5 chip using EDC/NHS for crosslinking in 10 mM 
sodium acetate pH 5. Unoccupied sites were blocked with 1 M ethanolamine. OP-peptides in 
10 mM HEPES buffer pH 7.4, 150 mM NaCl, 3 mM EDTA, 0.05% (v/v) 
polyoxyethylenesorbitan were injected at a flow rate of 30 μL/min. Rate constants were 
measured for the following OP-peptides and the corresponding unlabeled peptide controls: 
YPF-OP and YPF; GGYP-OP and GGYP; LYGLPR-OP and LYGLPR; PPYRM-OP and 
PPYRM. OP-peptide concentrations ranged from 0 to 1000 nM. After each assay the chip 
was regenerated with 10 mM glycine pH 1.75. The surface plasmon resonance signal 
obtained in each individual reaction cycle was recorded as a sensorgram, which is a real-
time pattern plotted in response units versus time. BIAevaluation T-200 soft-ware (version 
2.0) was used to calculate the equilibrium binding affinity constant Kd. Chi square analysis 
was carried out between the actual sensorgram and the sensorgram generated from the 
BIAnalysis software to determine the accuracy of the analysis. A Chi square value below 1 
is highly significant.
Kd of OP-proteins evaluated by Bio-Layered Interferometry on OctetRED96
Assays were performed by Dr. Udaya Yerramalla on the OctetRED96 instrument using Bio-
Layer Interferometry, a label-free technology for measuring bio-molecular interactions. The 
depY antibody at 20 μg/mL was captured on a biosensor which had been coated with anti-
mouse IgG Fc. The following samples were tested for binding to depY: porcine tubulin-OP 
and porcine tubulin control; casein-OP and casein control; ovalbumin-YPF-OP and 
ovalbumin-YPF control; BSA-LYGLPR-OP and BSA-LYGLPR control. Rate constants for 
association and dissociation were measured using sample concentrations of 100, 50, 25, 
12.5, or 6.25 nM in PBS, 0.01% BSA, 0.002% Tween-20. Probes were dipped into buffer to 
measure the dissociation rate. The sensor surface was regenerated after each binding 
experiment with 10 mM glycine pH 1.75. The traces were processed using ForteBio Data 
Analysis Software (version 8.0, Pall ForteBio, CA, USA) and fit globally using a simple 1:1 
Langmuir interaction model.
Sequence and Isotype of purified depY
Syd Labs Inc. sequenced the cDNA of depY using 5′ and 3′ RACE (Rapid Amplification 
of cDNA Ends). To verify that the correct sequence had been captured from the hybridoma 
cells, the cDNA was cloned into expression vectors, transiently expressed in HEK293 cells 
and the secreted recombinant antibody purified on Protein A agarose beads. The 
recombinant depY antibody was tested by ELISA against a panel of 12 diethoxyphospho-
tyrosine proteins and unlabeled control proteins. A duplicate 96-well plate was hybridized 
with depY purified from hybridoma cells. The isotype was determined by searching the 
cDNA sequence against the UniProt database.
Liquid chromatography tandem mass spectrometry (LC-MS/MS)
Data acquisition was performed with a Triple-TOF 6600 mass spectrometer (ABI Sciex, 
Framingham, MA) fitted with a Nanospray III source (AB SCIEX, Framingham, MA) and a 
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Pico Tip emitter (# FS360-20-10-N-5-C12, New Objectives, Woburn, MA). The ion spray 
voltage was 2700 V, declustering potential 60 V, curtain gas 30 psi, nebulizer gas 10 psi, and 
interface heater temperature 150°C.
Peptides were introduced into the mass spectrometer using ultra high pressure liquid 
chromatography. A splitless Ultra 1D Plus ultrahigh pressure chromatography system 
(Eksigent, Dublin, CA) was coupled to the Triple-TOF via a cHiPLC Nanoflex microchip 
column system (Eksigent, Dublin, CA). The Nanoflex system uses a replaceable 
microfluidic trap column and a replaceable separation column. Both are packed with 
ChromXP C18 (3 μm, 120 A particles; Trap: 200 μm × 0.5 mm; Separation: 75 μm × 15 cm). 
Chromatography solvents were water/acetonitrile/formic acid (A: 100/0/0.1%, B: 
0/100/0.1%). Picomole amounts of sample, in a 5 μl volume, were loaded. Trapping and 
desalting were carried out at 2 μL/min for 15 minutes with 100% mobile phase A. 
Separation was obtained with a linear gradient 5%A/95%B to 70%A/30% B over 60 min at 
a flow rate of 0.3 μL/min.
Statistics
Biacore and Octet data were fit to a 1:1 binding model. The accuracy of the reported Kd 
values was determined from Chi2 values. Chi2 is a measure of the average deviation of the 
experimental data from the fitted curve. Values less than 1 indicate an excellent fit. R2 is an 
estimate of the goodness of the fit. Values close to 1 indicate excellent fit.
Results
Antigen structure
OP adducts on the active site serine of AChE and BChE dealkylate in a process called aging. 
In contrast, diethoxyphospho adducts on tyrosine do not age.10–13, 15, 16 MALDI-TOF/TOF 
mass spectrometry analysis of OP-peptides confirmed that all carried the diethoxyphosphate 
group on tyrosine shown in Figure 1 and none had aged to monoethoxyphosphate. However, 
we found that the dimethoxyphospho-tyrosine adduct on peptide GGYR, produced by 
reaction with dichlorvos, spontaneously aged to the monomethoxyphospho-tyrosine adduct, 
confirming a result previously reported by Bui-Nguyen et al. (2014).8
Monoclonal antibody depY recognizes diethoxyphospho-tyrosine independent of the 
amino acid context of the modified tyrosine
The initial ELISA screen of 30 hybridoma culture media yielded 4 samples that gave a good 
signal with human albumin-OP and mouse albumin-OP and no signal for control human and 
mouse albumin. A good signal was defined as absorbance at 405 nm in the range 0.2 to 0.4 
after 20 min reaction with the HRP substrate. No signal was defined as background 
absorbance of 0.07 to 0.09 under the same conditions. After monoclonal antibodies from the 
4 hybridoma culture media were purified and tested against a variety of diethoxyphospho-
tyrosine proteins, one outperformed the others in terms of signal intensity in ELISA. DepY 
was selected for further characterization.
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ELISA and Western blot results summarized in Table 1 show that monoclonal antibody 
depY recognized peptides and proteins containing diethoxyphospho-tyrosine regardless of 
the amino acid context of the OP-tyrosine. Two types of OP-labeled samples were tested in 
Table 1. One type was prepared by conjugating specific OP-tyrosine peptides to a carrier 
protein, for example, peptide QYDVRK-OP diethoxyphosphorylated on tyrosine was 
conjugated to human albumin. The second type of OP-modified sample was prepared by 
incubating proteins with chlorpyrifos oxon. Amino acid sequences around the OP-tyrosine 
and the percent modification in casein-OP, tubulin-OP, human albumin-OP, lysozyme-OP, 
and aprotinin-OP are provided in Appendix S1 in the Supporting Information section. Table 
1 shows a range of %OP-Tyr in OP-proteins because some tyrosines were labeled 
extensively, whereas other tyrosines in the same protein were minimally labeled. For 
example, 13 tyrosines were diethoxyphosphorylated in the porcine tubulin alpha-1A chain, 
with the extent of modification ranging from 7% for Tyr357 to 69% for Y103 (see Appendix 
S1). Similarly, 13 tyrosines were diethoxyphosphorylated in the porcine tubulin alpha-1B 
chain, with the extent of modification ranging from 6% for Tyr83 to 67% for Tyr 103.
Table 1 shows a rough correlation between the number of OP-Tyr peptides crosslinked per 
protein molecule and signal intensity in ELISA. For example lysozyme-PYYMRR-OP with 
only 1 OP-peptide bound per lysozyme molecule had a weaker signal in ELISA than 
lysozyme-GGYR-OP with 4, 10 and 16 OP-peptides bound. A similar rough correlation was 
observed for OP-proteins. For example, aprotinin-OP was modified on only one of its 4 
tyrosine residues and only 10% of Tyr56 was diethoxyphosphoryalted. In contrast, porcine 
tubulin was modified on 13 out of 19 tyrosine residues in the alpha chains and on 8 and 11 
out of 16 tyrosines in the beta chains. The level of modification ranged from 6 to 69%. 
Signal intensity for tubulin-OP was exceptionally high in Western blots, whereas signal 
intensity for aprotinin-OP was low.
It was concluded that depY recognized diethoxyphospho-tyrosine independent of the amino 
acid sequence around OP-tyrosine. This feature makes it possible to use the depY antibody 
in any species to search for unknown proteins diethoxyphosphorylated on tyrosine.
DepY does not recognize OP-lysine
Appendix S1 shows that proteins treated with chlorpyrifos oxon were modified on tyrosine 
and lysine. The exception was casein, which was modified exclusively on tyrosine. To 
determine whether depY recognized diethoxyphospho-lysine, we prepared 
diethoxyphospho-lysine and conjugated it to human albumin. The conjugated albumin bound 
14 OP-lysine per albumin molecule. An immulon plate coated with 1 μg of OP-lysine-
albumin per well, or with the positive control OP-tubulin was probed with 0.2 μg/100 μL of 
depY. We used a 10-fold higher antibody concentration than in our standard assays to 
overcome potential poor binding affinity. ELISA detected no binding of depY to OP-lysine-
albumin, but strong binding to the positive control, OP-tubulin. It was concluded that depY 
does not recognize diethoxyphosphorylated-lysine.
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DepY does not recognize phospho-tyrosine
Hundreds of proteins in a cell are phosphorylated on tyrosine at various times during the life 
a cell.14 The possibility that depY recognizes phospho-tyrosine was ruled out in a 
competition ELISA experiment. The competition ELISA was set up so that the antibody 
would be unavailable to bind OP-protein coated on the 96-well plate if O-phospho-tyrosine 
binds to the antibody in solution. DepY diluted to 0.1 μg/mL in 1% BSA/TBS was incubated 
with 10−3 to 10−13 M phospho-tyrosine for 1 h at room temperature. The antibody sites 
available for binding to human albumin-YGGFL-OP in a 96-well plate were evaluated by 
standard ELISA methods. It was found that binding of depY to human albumin YGGFL-OP 
was unaffected by the presence of phospho-Tyr. In conclusion, depY does not recognize 
phospho-Tyrosine.
Anti-phospho-L-tyrosine monoclonal antibody does not recognize diethoxyphospho-
tyrosine
To determine whether anti-phospho-tyrosine monoclonal antibody PY20 recognized 
diethoxyphospho-tyrosine, we conjugated O-phospho-L-tyrosine to human albumin to serve 
as a positive control. Test samples in Figure 2 included lysozyme-PYMRR-OP, BSA-
LYGLPR-OP, human albumin-QYDVRK-OP, human albumin-YGGFL-OP, control human 
albumin, porcine tubulin-OP, control porcine tubulin, and the positive control, O-phospho-L-
tyrosine crosslinked to human albumin. The Western blot in Figure 2 shows that none of the 
diethoxyphospho-tyrosine samples (lanes 1–7) hybridized with PY20, but the positive 
control sample in lanes 8 and 9 gave a strong signal. Monomers, dimers, and multimers of 
the positive control sample in lanes 8 and 9 were formed during the crosslinking reaction 
with EDC. It was concluded that monoclonal antibody PY20 does not recognize 
diethoxyphospho-tyrosine-proteins, but does recognize the positive control O-phospho-L-
tyrosine crosslinked to human albumin.
DepY does not recognize dichlorvos-modified tyrosine
DepY immobilized on Sepharose beads was incubated with dichlorvos-modified GGYR and 
chlorpyrifos oxon modified YGGFL to determine whether the antibody captured both types 
of modified tyrosine. Dichlorvos treatment produced the dimethoxyphospho adduct on 
tyrosine, a portion of which aged to the monomethoxyadduct. Chlorpyrifos oxon treatment 
produced the diethoxyphospho adduct on tyrosine, but no monoethoxyphospho adduct (no 
aged adduct). After beads were washed with PBS and water, the captured peptides were 
released with 50% acetonitrile, 1% TFA and identified by their masses in the 4800 Triple 
TOF mass spectrometer. Panel A in Figure 3 shows masses at 546.2 (monomethoxyphospho 
adduct) and 560.2 Da (dimethoxyphospho adduct) for the dichlorvos-modified peptide 
GGYR and masses at 692.2 (diethoxyphospho adduct) and 714.2 Da (diethoxyphospho 
adduct plus a sodium ion) for the CPO-modified peptide YGGFL before the peptides were 
treated with immobilized antibody. Panel B shows the peptides that were captured by the 
immobilized antibody; there are no masses for dichlorvosmodified GGYR at 546.2 and 
560.2 Da, but there are strong signals for diethoxyphospho-YGGFL (chlorpyrifos oxon-
modified) at 692.2 and its sodium ion at 714.2 Da. It was concluded that depY recognizes 
chlorpyrifos oxon modified-tyrosine, but not dichlorvos-modified tyrosine.
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Specificity of monoclonal antibody depY for diethoxyphospho-tyrosine
Our goal was to determine whether monoclonal antibody depY recognized adducts in 
addition to diethoxyphospho-tyrosine. Naturally-occurring phospho-serine and phospho-
threonine are present in casein. Phosphosite.org shows a total of 34 phospho-Ser and 
phospho-Thr sites in the casein isozymes. Control, untreated casein was not detected in 
ELISA or in Western blots, indicating that depY does not recognize phospho-serine or 
phospho-threonine.
A mixture of phospho-serine and cresylphospho-serine modified sites was created by 
inhibiting human butyrylcholinesterase (BChE) with cresyl saligenin phosphate, the toxic 
metabolite of tri-o-cresylphosphate.17, 18 This reagent makes a covalent bond with the active 
site serine 198 of human BChE to yield the phospho- and cresylphospho-serine 
modifications. A dimethoxyphospho adduct on the active site serine of BChE was prepared 
by inhibiting BChE with dichlorvos, and a diethoxyphospho adduct by inhibiting BChE with 
CPO. The inhibited BChE samples were boiled to unfold the protein and thus make available 
the active site serine residue, which in the native protein is buried deep inside the active site 
gorge.19 The boiled samples were coated on an immulon plate where binding of depY was 
evaluated by standard ELISA methods. The result showed that depY does not bind phospho-
serine and cresylphospho-serine (BChE inhibited by cresyl saliginen phosphate, 
diethoxyphospho-serine (BChE inhibited by CPO), and dimethoxyphosphoserine (BChE 
inhibited by dichlorvos). It was concluded that depY does not recognize phospho-serine, 
phospho-threonine, diethoxyphospho-serine, dimethoxyphospho-serine, and cresylphospho-
serine. Table 2 summarizes the hapten structures that were tested and found to be unreactive 
with depY.
Limit of detection
The Western blot in Figure 4 shows that depY detects as little as 25 ng of human albumin 
conjugated to OP-YGGFL. The albumin conjugate has 5 bands on the Western blot because 
the crosslinking agent EDC crosslinked albumin to itself to form albumin dimers, trimers, 
tetramers, and pentamers.
Competition ELISA to measure IC50
Binding of depY to human albumin-QYDVRK-OP coated on a 96-well immulon plate was 
observed in Figure 5 after the antibody was incubated with 10−17 M to 10−7 M 
concentrations of porcine tubulin-OP. It was found that 50% of the sites in 0.1 μg/mL depY 
were occupied by 3 × 10−9 M porcine tubulin-OP.
Binding affinity of OP-peptides measured by Biacore analysis
Binding to depY of small peptides modified on tyrosine by diethoxyphosphate was 
measured on a Biacore instrument. Table 3 shows Kd values ranging from 10−7 to 10−8 M. 
The unlabeled control peptides did not bind to depY in 10 mM HEPES pH 7.4, 150 mM 
NaCl, 3 mM EDTA, 0.05% polyoxyethylenesorbitan.
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Binding affinity of OP-proteins measured by Bio-layer interferometry
Rate constants for association (kon) and dissociation (koff) were measured in an 
OctetRED96 instrument. Figure 6 shows the data for porcine tubulin-OP in panel A and for 
the control porcine tubulin in panel B. Table 4 shows that Kd values (koff divided by kon) 
were less than 1 × 10−12 M for porcine tubulin-OP, casein-OP, ovalbumin crosslinked to 
YPF-OP, and bovine albumin crosslinked to LYGLPR-OP. It was concluded that proteins 
labeled on tyrosine by diethoxyphosphate are tightly bound to monoclonal antibody depY 
despite the presence of 0.15 M sodium chloride in the assay buffer.
Sequence and Isotype IgG2a kappa of depY
The recombinant depY with the sequence shown in Figure 7 had the same binding 
specificity as depY purified from hybridoma cells when tested by ELISA against a panel of 
12 OP-tyrosine proteins. The unlabeled control proteins bound neither the recombinant nor 
the hybridoma depY. This result confirmed that the sequences in Figure 7 represent depY. 
The isotype of depY is IgG2a kappa. The nucleotide and translated amino acid sequences, 
have been deposited in GenBank.
Discussion
Rationale for choosing diethoxyphospho-tyrosine as target
This is the first report of a monoclonal antibody to the diethoxyphospho-tyrosine adduct on 
proteins independent of the amino acids around the modified tyrosine. The depY 
monoclonal antibody is expected to recognize adducts on any protein from any animal.
We and others have demonstrated that humans poisoned with organophosphorus pesticides 
have adducts on tyrosine 411 of serum albumin.2, 9, 11 We hypothesize that not only albumin 
but also other proteins are modified on tyrosine, but that these additional proteins occur in 
low abundance and need to be enriched before they can be identified. An antibody to OP-
tyrosine would aid in identification of these hypothetical adducts. The hypothetical adducts 
could be proteins that are naturally phosphorylated and dephosphorylated during cell growth 
and differentiation20–22, but whose function is disrupted when they are irreversibly modified 
by OP.
Another good candidate for production of a monoclonal antibody would be Lysine- OP 
because lysines were modified in almost all the proteins we treated with CPO. V-type nerve 
agents have been demonstrated to phosphonylate 6 lysine residues in ubiquitin23 that are 
essential for the biological function of ubiquitin. Acetylated and methylated lysines are 
reversible posttranslational modifications that play key roles in regulating gene expression.
24, 25 These functions could be impaired when lysine is irreversibly modified by OP. An 
antibody to OP-lysine together with antibodies to OP-tyrosine and OP-serine7 would be 
useful in future studies aimed at understanding chronic illness from OP exposure.
Limitation of monoclonal antibody depY
Tubulin and other proteins that are diethoxyphosphorylated on several residues are bound 
with high affinity (Kd 10−12 M) by monoclonal antibody depY, but peptides modified on a 
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single tyrosine are bound with lower affinity (Kd 10−8 M). It may be possible to generate a 
higher affinity antibody in rabbit or by single B cell cloning.26, 27
Antibodies to organophosphorus adducts in the literature
Exposure to organophosphorus pesticides is accompanied by irreversible modification of the 
active site serine of AChE and BChE accompanied by loss of enzyme activity and toxicity. 
Common insecticide oxons such as chlorpyrifos oxon and paraoxon add a 
diethoxyphosphate group to serine. Over the years, several laboratories have tried to make 
antibodies that distinguish modified from unmodified AChE. The major difficulty in making 
such an antibody has been the fact that O-phosphylated-serine is unstable in vivo.7, 28 
Animals produced no antibody because the phosphylated-serine was converted to 
dehydroalanine with loss of the ligand. This problem was solved by the group of Charles 
Thompson at the University of Montana by substituting a CH2 group for the side-chain OH 
in serine.7 The substitution prevented the phosphylated serine homolog from undergoing a 
beta-elimination reaction with loss of the OP ligand. They succeeded in producing 
monoclonal antibodies that recognize diethoxyphosphorylated-serine and 
monoethoxyphosphorylated-serine. Furthermore, they made their monoclonal antibodies 
available through neuromab.ucdavis.edu.
Monoclonal antibodies have been generated that recognize the pinacolyl methyl 
phosphonate (soman) and the VX adducts on tyrosine 411 of albumin.29 The monoclonals 
were made to a nerve-agent modified, 10-residue peptide of human albumin and are specific 
for adducts on albumin. Binding affinity evaluated by competition ELISA was in the 
nanomolar range.
Several laboratories have made monoclonals to a soman hapten for the purpose of 
neutralizing soman before it reacted with AChE.30–32 The monoclonals had limited success 
because they lacked sufficient affinity to reduce the in vivo concentration of soman to non-
toxic levels.
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Refer to Web version on PubMed Central for supplementary material.
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BSA bovine serum albumin
CPO chlorpyrifos oxon
DepY mouse monoclonal antibody to diethoxyphospho-tyrosine
EDC 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide.HCl
ELISA enzyme linked immunosorbent assay
HRP horse radish peroxidase
HSA human serum albumin
IC50 The half maximal inhibitory concentration
Kd equilibrium dissociation constant (koff/kon)
LC-MS/MS liquid chromatography tandem mass spectrometry
MALDI-TOFmatrix assisted laser desorption ionization- time of flight mass spectrometry
MES 2-[N-morpholino]ethanesulfonic acid
OP diethoxyphospho adduct produced by reaction with chlorpyrifos oxon or 
paraoxon
OVA ovalbumin
PBS phosphate buffered saline
Sulfo-NHS N-hydroxysulfosuccinimide
TBS Tris buffered saline 20 mM TrisCl, 0.15 M NaCl pH 7.4
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Structure of diethoxyphospho-tyrosine, the antigen for antibody production. In this 
manuscript the abbreviation OP is used specifically for the diethoxyphospho adduct.
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Western blot hybridized with monoclonal antibody PY20 to phosphotyrosine. The SDS gel 
was loaded with 1 μg protein per lane. 1) lysozyme-PYMRR-OP, 2) BSA-LYGLPR-OP, 3) 
human albumin-QYDVRK-OP, 4) human albumin-YGGFL-OP, 5) control human albumin, 
6) tubulin-OP, 7) control tubulin, 8) and 9) O-phospho-L-tyrosine-crosslinked to human 
albumin. Monoclonal antibody PY20 specifically recognized phosphotyrosine-labeled 
protein, but did not recognize diethoxyphosphorylated tyrosine labeled proteins.
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Immuno MALDI demonstrating specific capture of diethoxyphospho-tyrosine modified 
peptide by antibody depY. A) Peptides before incubation with immobilized antibody. 
Dichlorvos-modified peptide GGYR has masses at 560.2 Da for the dimethoxyphospho 
adduct and 546.2 Da for the aged monomethoxyphospho adduct. Chlorpyrifos oxon 
modified peptide YGGFL has masses at 692.2 Da for the diethoxyphospho adduct on 
YGGFL and 714.2 Da for the sodiated ion. B) Peptides captured by the antibody were 
identified as the diethoxyphospho adduct on YGGFL. No ions for the dichlorvos-modified 
peptide were observed. C) Negative control beads (no antibody) captured no 
diethoxyphospho-Tyr modified peptides.
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Limit of detection of human albumin conjugated to OP-YGGFL (5 OP-peptides bound per 
albumin molecule). The SDS gel was loaded with 100 to 5 ng of antigen per lane. The 
Western blot was hybridized with 0.14 μg/mL depY.
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Binding affinity of depY for porcine tubulin-OP. The IC50 is 3 × 10−9 M.
Onder et al. Page 22














Binding affinity of depY monoclonal antibody determined by biolayer interferometry using 
an OctetRED96 instrument. A) Binding and dissociation of porcine tubulin-OP modified on 
tyrosine by diethoxyphosphate. B) No binding to control porcine tubulin. The depY 
monoclonal antibody was captured on an anti-mouse IgG biosensor. A concentration series 
of 100, 50, 25, 12.5 and 6.25 nM porcine tubulin-OP was used to determine the association 
and dissociation rate constants and the binding affinity for depY. The data points are 
represented by wavy lines and the fitted data are shown as solid lines.
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Amino acid sequences of the variable heavy and light chains of depY. The complementarity 
determining regions (CDR) were defined by IMGT/V-QUEST, http://www.imgt.org. 
GenBank accession numbers are MG182361 and MG182362.
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Table 1
DepY recognizes diethoxyphospho-tyrosine independent of the amino acid sequence around the modified 
tyrosine*
Antigen ELISA Western blot # OP-Tyr/protein %OP-Tyr
Hu albumin-QYDVRK-OP +++ ++++ 7
Hu albumin control − − 0
Hu albumin-YGGFL-OP +++ ++++ 5
Bovine albumin-LYGLPR-OP +++ ++++ 16
Bovine albumin control − − 0
Lysozyme-GGYR-OP ++++ NA 4, 10 & 16
Lysozyme-RARYEM-OP ++++ NA 6 & 9
Lysozyme-PYYMRR-OP +++ ++ 1
Lysozyme control − − 0
Ovalbumin-RSLYAS-OP +++ NA 18 & 22
Ovalbumin-YPF-OP ++++ NA 6 & 14
Ovalbumin-YGGFL-OP ++++ NA 5, 9 & 12
Ovalbumin control − NA 0
Casein-OP (OP on Tyr) +++ +++ 10–95%
Casein control − − 0
Bovine tubulin-OP (OP on Tyr + Lys) +++ +++++ 12–26%
Bovine tubulin control − − 0
Porcine tubulin-OP (OP on Tyr + Lys) +++ +++++ 6–69%
Porcine tubulin control − − 0
Human albumin-OP (OP on Tyr + Lys) + − 21–98%
Lysozyme-OP (OP on Tyr + Lys) +++ − 3–5%
Aprotinin-OP (OP on Tyr + Lys) ++ + 10%
Aprotinin control − − 0
Mouse albumin-OP (OP on Tyr + Lys) +++ NA 83%
Mouse albumin control − NA 0
*
OP refers to the diethoxyphospho adduct on tyrosine. The OP adduct is exclusively on tyrosine in the peptides and in casein. The OP adduct is on 
both tyrosine and lysine in human albumin, bovine tubulin, porcine tubulin, lysozyme, and aprotinin. However, monoclonal antibody depY does not 
recognize OP-Lys adducts. The (+) symbol represents signal intensity, where (+++++) represents the highest and (+) the lowest positive signal. The 
symbol (−) represents a negative result. NA is the symbol for data not available. # OP-Tyr/protein is the number of diethoxyphospho-Tyr peptides 
crosslinked per protein molecule as determined by MALDI-TOF mass spectrometry. %OP-Tyr refers to the percent OP labeling of multiple 
tyrosines in the protein where the identity of each OP-modified tyrosine and the extent of labeling was determined by LC-MS/MS; the location of 
the OPlabeled tyrosines and the % modified in each protein is described in Supporting Information Appendix S1.
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Table 2






dimethoxyphospho-serine protein phospho-threonine protein
monomethoxyphospho-tyrosine protein
o-cresylphospho-serine protein
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Table 3
Binding affinity measured on Biacore T-200 of monoclonal antibody depY for peptides modified on tyrosine 
by diethoxyphosphate
Peptide Kd, M Chi2
YPF-OP 4.1 × 10−7 0.0076
YPF control No binding -
GGYR-OP 5.3 × 10−8 0.506
GGYR control No binding -
LYGLPR-OP 1.2 × 10−8 0.0263
LYGLPR control No binding -
PPYRM-OP 3.6 × 10−7 0.361
PPYRM control No binding -
Chi2 values below 1 are highly significant. The dash indicates Chi2 values too low to be measureable.
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